BiotechTube
Home/Tempo Therapeutics/Stephanie Deshayes, PhD
SD

Stephanie Deshayes, PhD

VP R&D

Tempo Therapeutics

Therapeutic Areas

Surgical OncologySoft Tissue ReconstructionWound Healing

Tempo Therapeutics Pipeline

DrugIndicationPhase
MAP Biosurgery Product (e.g., TT101)Soft tissue reconstruction (Dermal and Abdominal Wall)Pre-clinical

Leadership Team at Tempo Therapeutics

WW
Westbrook Weaver, PhD
Founder & CEO
DG
Donald Griffin, PhD
Founder & CSO
KU
Kwame Ulmer
Chief Regulatory Officer
TS
Tatiana Segura, PhD
Founder, Scientific Advisor
View full Tempo Therapeutics profile